Having a child recipient and helping someone in need – especially if they knew them – were among the top reasons that people ...

Chronic spontaneous urticaria is chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden ...

Maureen Corcoran, director of the Ohio Department of Medicaid, believes the work requirement policy can be both a financial ...

A panelist discusses how type 1 diabetes (T1D) is frequently misdiagnosed in adults due to its overlapping clinical features with type 2 diabetes (T2D), resulting in inappropriate treatment strategies ...

Oncologists should ask in advance about what young patients and their parents want to be told about changing prognoses, a new ...

A trial found magnetic resonance imaging correlated with physical function tests in patients with Duchenne muscular dystrophy ...

New research shows that Medicaid expansion was linked to a 2.1% increase in timely lung cancer surgeries and a 2.8% rise in ...

Medicaid is the main healthcare coverage for people living with HIV in the United States, according to data compiled by KFF.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

If approved, Eylea would be the first treatment for RVO with 8-week dosing. The FDA target action date is Aug. 19, 2025.

Panelists discuss how, cemiplimab, a PD-1 inhibitor, has shown promise as a second-line therapy for advanced NSCLC after progression on prior treatments. Continuing cemiplimab post-progression can ...

Panelists discuss how, as new data on cemiplimab and other checkpoint inhibitors emerge, the treatment pathway for cancers like non-small cell lung cancer (NSCLC) is expected to evolve toward more ...